Motor Neuron Diseasea Review

Charcot JM . Lecons sur les maladies du système nerveux faites à la Salpétrière. Paris: Progrès Medical, 1877: 213–42.

Chancellor AM , Warlow CP . Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992; 55: 1106–1115.

Chancellor A , Swingler RJ , Fraser H & Warlow CP for the Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: A prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992; 55: 536–541.

Chancellor AM , Slattery JM , Fraser H , Swingler RJ , Holloway SM , Warlow CP . The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993; 240; 339–46.

Rowland LP . Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998; 160S:6-24.

World Federation of Neurology Research Group on Neuromuscular Disease. El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124S:96-107.

Davenport RJ , Swingler RJ , Chancellor AM , Warlow CP . on behalf of the Scottish Motor Neuron Disease Register. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996; 60: 147–51.

Website address. http://www.wfnals.org/Airliecriteria/

Ross MA , Miller RG , Berchert L Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised criteria. RhCNTF ALS Study Group. Neurology 1998; 50: 768–72.

Van den Berg LH , Kerkhoff H , Oey PL Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulin: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995; 59: 248–52.

Van den Berg LH , Franssen H , Wokke JHJ . Improvement of multifocal motor neuropathy during long term weekly treatment with human immunoglobulin. Neurology 1995; 45: 987–88.

Bouche P , Moulonguet A , Younes-Chennoufi AB Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995; 59: 38–44.

Ellis CM Leary S , Payan J Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 1999; 67: 15–19.

La Spada AR , Wilson EM , Lubahn DB , Harding AE , Fischbeck KH . Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79. Letter.

Parboosingh JS , Figlewicz DA , Krizus A Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS. Neurology 1997; 49: 568–72.

Chancellor AM , Slattery JM , Fraser H , Warlow CP for the Scottish Motor Neuron Disease Research Group. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1993; 56: 1200–1296.

Rosen DR , Siddique T , Patterson D Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62. Letter.

Hayward C , Colville S , Swingler RJ , Brock DJH . Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 1999; 52: 1899–1901.

Al-Chalabi A , Enayat Z , Bakker M Association of apolipoprotein E e4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159–160.

Bachus R , Bader S , Gessner R , Ludolph AC . Lack of Association of Apolipoprotein E epsilon 4 Allele with Bulbar-onset Motor Neuron Disease. Ann Neurol 1997; 41: 417.

Lin CL , Bristol LA , Jin L Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.

Meyer T , Munch C , Völkel H , Booms P , Ludolph AC . The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 1998; 65: 594–96.

Figlewicz DA , Krizus A , Martinoli MG Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757–61.

Lee MK , Marszalelc IR , Cleveland DW . A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994; 13: 975–88.

Guidelines for the management of motor neurone disease (MND) prepared by the Excerpta Medica MND Advisory Group Distributed to members of the Association of British Neurologists (unpublished).

Miller RG , Rosenberg JA , Gelinas DF Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52: 1311–23.

Here to help. Scottish Motor Neurone Disease Association c/o 76 Firhill Road, Glasgow G20 7BA.

Bensimon G , Lacomblez L , Meininger V and the ALS/Riluzole Study group. A controlled trial of Riluzole in Amyotrophic Lateral Sclerosis. N Engl J Med 1994; 330: 585–591.

Lacomblez L , Bensimon G , Leigh PN Dose-ranging study of riluzole in amyotrophic lateral sclerosis. The Lancet 1996; 347: 1425–1431.

Miller RG , Bouchard JP , Duquette P. Clinical trials of riluzole in patients with ALS. Neurology 1996; 47 (suppl 2): S86–S92.

Rowland LP . Riluzole for the treatment of amyotrophic lateral sclerosis: too soon to tell? N Engl J Med. 1994; 330: 636–637.

Borasio G , Robberecht W , Leigh PN A placebo-controlled trial of insulin-like growth factor-1 in amyotrophic lateral sclerosis. Neurology 1998; 51: 583–586.

The BDNF Study Group. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology 1999; 52: 1427–33.

ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rh CNTF) in amyotrophic lateral sclerosis. Neurology 1996; 46: 1244–1249.

Gurney ME , Pu H , Chiu AY Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264: 1772–75.

Mazzini L , Corra T , Zaccala M , Mora G , Del Piano M , Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995: 242; 695–698.

Kasarskis EJ , Neville HE Management of ALS: Nutritional care. Neurology 1996 47; [suppl 2]: S118–S120.

Aboussouan LS , Khan SLU , Meeker DP , Stelmach K , Mitsumoto H . Effect of non-invasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997, 127: 450–453.

Borasio GD , Gelinas DF , Yanagisawa N. Mechanical ventilation in ALS: a cross-cultural perspective. J Neurol 1998 [Suppl 2]: S7–12.